JOURNAL OF COSMETIC SCIENCE 88 our patients wished to continue using the product after the 1-mo period. Future research should follow the cohort for longer than 1 mo to uncover whether longer use of this prod- uct could result in potentially better outcomes. Last, some may argue that the formulation’s moisturizing vehicle by itself could induce enhanced moisturization of the skin and improve the appearance of SD. Future studies should use a split study of our formulation versus a placebo moisturizer. CONCL USION This study demonstrates that the investigated topical formulation is safe and effective to use for SD. It can help improve the appearance and texture of SD. It may also be consid- ered for use in helping to prevent SD, as prior evidence supports the use of topical creams in preventing the formation of new SD, especially in pregnant women. Autho r Disclosure: Christopher I. Zoumalan, MD, owns stock and is the scientifi c advisor for MD Medical Designs, Inc., Los Angeles, CA, manufacturer of the stretch mark cream used in this study. ACKNO WLEDGMENT We th ank Cristina Luna for her research-coordinating support. REFER ENCES (1) A . L. S. Chang, Y. Z. Agredano, and A. B. Kimball, Risk factors associated with striae gravidarum, J. Am. Acad. Dermatol., 51(6), 881–885 (2004). (2) K. H. Kelekci, S. Kelekci, E. Destegul, A. Aksoy, N. Sut, and B. Yilmaz, Prematurity: is it a risk factor for striae distensae? Int. J. Dermatol., 50(10), 1240–1245 (2011). (3) A. Hague and A. Bayat, Therapeutic targets in the management of striae distensae: a systematic review, J. Am. Acad. Dermatol., 77(3), 559–568 (2017). (4) B. J. Kim, D. H. Lee, M. N. Kim, K. Y. Song, W. I. Cho, C. K. Lee, and O. S. Kwon, Fractional pho- tothermolysis for the treatment of striae distensae in Asian skin, Am. J. Clin. Dermatol., 9(1), 33–37 (2008). (5) S. Kang, Topical tretinoin therapy for management of early striae, J. Am. Acad. Dermatol., 39(2), S90– S92 (1998). (6) M. C. A. Issa, L. E. de Britto Pereira Kassuga, N. S. Chevrand, L. do Nascimento Barbosa, R. R. Luiz, L. Pantaleão, E. G. Vilar, and M. C. Rochael, Transepidermal retinoic acid delivery using ablative frac- tional radiofrequency associated with acoustic pressure ultrasound for stretch marks treatment, Laser Surg. Med., 45(2), 81–88 (2013). (7) S. Guida, M. G. Galimberti, M. Bencini, G. Pellacani, and P. L. Bencini, Treatment of striae distensae with non-ablative fractional laser: clinical and in vivo microscopic documentation of treatment effi cacy, Laser Med. Sci., 33(1), 75–78 (2018). (8) V. Mishra, L. Miller, S. M. Alsaad, and E. V. Ross, The use of a fractional ablative micro-plasma radio- frequency device in treatment of striae, J. Drugs Dermatol. JDD, 14(11), 1205–1208 ( 2015). (9) H. Bak, B. J. Kim, W. J. Lee, J. S. Bang, S. Y. Lee, J. H. Choi, and S. E. Chang, Treatment of striae distensae with fractional photothermolysis, Dermatol. Surg., 35(8), 1215–1220 (2009). (10) F. Malekzad, S. Shakoei, A. Ayatollahi, and S. Hejazi, The safety and effi cacy of the 1540nm non-ablative fractional XD probe of star lux 500 device in the treatment of striae alba: before-after study, J. lasers Med. Sci., 5(4), 194 (2014).

NEW TOPICAL SILICONE FORMULATION FOR TREATING STRIAE DISTENSAE 89 (11) Y. J. Yang and G. Y. Lee, Treatment of striae distensae with nonablative fractional laser versus ablative CO2 fractional laser: a randomized controlled trial, Ann. Dermatol., 23(4), 481–489 (2011). (12) W. Disphanurat, A. Kaewkes, and W. Suthiwartnarueput, Comparison between topical recombinant human epidermal growth factor and Aloe vera gel in combination with ablative fractional carbon diox- ide laser as treatment for striae alba: a randomized double-blind trial, Laser Surg. Med., 52, 166–175 (2020). (1 3) S. Ud-Din, S. L. McAnelly, A. Bowring, S. Whiteside, J. Morris, I. Chaudhry, and A. Bayat, A double- blind controlled clinical trial assessing the effect of topical gels on striae distensae (stretch marks): a non-invasive imaging, morphological and immunohistochemical study, Arch. Dermatol. Res., 305(7), 603–617 (2 013). (1 4) P. Morganti, P. Palombo, G. Fabrizi, M. Palombo, and S. Persechino, Biweekly in-offi ce injectable treat- ment of striae distensae vs a long-term daily use of topical vitamin C, J. Appl. cosmetology, 19(4), 107– 112 (2 001). (1 5) D. de Lacerda, Striae distensae: the fi brillin/transforming growth factor beta signaling puzzle, Skinmed, 10(6), 338 (2 012). (1 6) M. Hajhashemi, M. Rafi eian, H. A. Rouhi Boroujeni, S. Miraj, S. Memarian, A. Keivani, and F. Haghollahi, The effect of aloe vera gel and sweet almond oil on striae gravidarum in nulliparous women, J. Maternal-Fetal Neonatal Med., 31(13), 1703–1708 (2 018). (1 7) Z. D. Draelos, M. H. Gold, M. Kaur, B. Olayinka, S. L. Grundy, E. J. Pappert, and B. Hardas, Evalua- tion of an onion extract, Centella asiatica, and hyaluronic acid cream in the appearance of striae rubra, Skinmed, 8(2), 80–86 (2010). ( 1 8) J. Mallol, M. A. Belda, D. Costa, A. Noval, and M. Sola, Prophylaxis of striae gravidarum with a topical formulation. A double blind trial, Int. J. Cosmet. Sci., 13(1), 51–57 (1991). ( 1 9) A. Sparavigna, M. Setaro, G. Manini, and C. Rigoni, Boswellic acid based cream is effective and well tolerated treatment for striae distensae, J. Appl. Cosmetol., 23, 93–104 (2005). ( 2 0) A. Hinek, H. J. Kim, Y. Wang, Wang, A., and T. F. Mitt, Sodium L-ascorbate enhances elastic fi bers deposition by fi broblasts from normal and pathologic human skin, J. Dermatol. Sci., 75(3), 173–182 (2014). (2 1 ) C. D. G. Hughes and A. Hedges, The use of an innovative fi lm-forming topical gel in preventing striae gravidarum and treating striae distensae, Australas. J. Dermatol., 60(1), 78–80 (2019). (22) C. I. Zoumalan, Topical agents for scar management: are they effective? J. Drugs Dermatol. JDD., 17(4), 421–425 (2018 ). (23) C. I. Zoumalan, S. C. Tadayon, J. Roostaeian, A. M. Rossi, and A. Gabriel, Safety and effi cacy of a scar cream consisting of highly selective growth factors within a silicone cream matrix: a double-blinded, randomized, multicenter study, Aesthet. Surg. J., 39, 319–330 (2019). (24) B. Bleasdale, S. Finnegan, K. Murray, S. Kelly, and S. L. Percival, The use of silicone adhesives for scar reduction, Adv. Wound Care, 4(7), 422–430 (2015). (25) K. C. Hsu, C. W. Luan, and Y. W. Tsai, Review of silicone gel sheeting and silicone gel for the preven- tion of hypertrophic scars and keloids, Wounds, 29(5), 154–158 (2017). (26) M. L. Elsaie, L. S. Baumann, and L. T. Elsaaiee, Striae distensae (stretch marks) and different modalities of therapy: an update, Dermatol. Surg., 35(4), 563–573 (2009 ). (27) J. F. Hermanns and G. E. Piérard, High-resolution epiluminescence colorimetry of striae distensae, J. Eur. Acad. Dermatol. Venereol., 20(3), 282–287 (2006). (28) G. S. S. Atwal, L. K. Manku, C. E. M. Griffi ths, and D. W. Polson, Striae gravidarum in primiparae, Br. J. Dermatol., 155(5), 965–969 (2006). (29) T. L eivo, P. Arjomaa, J. Oivula, M. Vesterinen, U. Kiistala, P. Autio, and A. Oikarinen, Differential modulation of transforming growth factor-β by betamethasone-17-valerate and isotretinoin: corticoste- roid decreases and isotretinoin increases the level of transforming growth factor-β in suction blister fl uid, Skin Pharmacol. Physiol., 13(3–4), 150–156 (2000). (30) K. S. Lee , Y. J. Rho, S. I. Jang, M. H. Suh, and J. Y. Song, Decreased expression of collagen and fi bro- nectin genes in striae distensae tissue, Clin. Exp. Dermatol., 19(4), 285–288 (1994). (31) L. Chen, J . Y. Hu, and S. Q. Wang, The role of antioxidants in photoprotection: a critical review, J. Am. Acad. Dermatol., 67(5), 1013–1024 (2012). (32) B. Amirla k , M. Mahedia, and N. Shah, A clinical evaluation of effi cacy and safety of hyaluronan sponge with vitamin C versus placebo for scar reduction, Plast. Reconstr. Surg. Glob. Open, 4(7), e792 (2016).